Source: |
Type: |
Protein Phosphatase 2A (PP2A) plays a critical role in Alzheimer’s disease (AD), especially in relation to tau pathology. -PP2A dephosphorylates tau, thus reducing its toxicity. -MID1 Negatively Regulates PP2A -In AD, PP2A activity is decreased, leading to accumulation of hyperphosphorylated tau. -Amyloid-β (Aβ) peptides may inhibit PP2A, indirectly promoting tau pathology. -Aβ and tau pathologies are interconnected, and PP2A sits at a crossroads of both. Some natural products that might upregulate PP2A: -resveratrol -Sodium selenate -Berberine -Fisetin -Metformin (via indirect mechanisms) |
4298- | BBR, | Berberine mitigates cognitive decline in an Alzheimer’s Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance |
- | in-vivo, | AD, | NA |
4302- | Gins, | Panax ginseng: A modulator of amyloid, tau pathology, and cognitive function in Alzheimer's disease |
- | Review, | AD, | NA |
4288- | RES, | Trans-resveratrol Inhibits Tau Phosphorylation in the Brains of Control and Cadmium Chloride-Treated Rats by Activating PP2A and PI3K/Akt Induced-Inhibition of GSK3β |
- | in-vivo, | AD, | NA |
4286- | RES, | Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease |
- | Review, | AD, | NA |
4284- | RES, | Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex |
- | in-vitro, | AD, | HEK293 | - | NA, | Stroke, | NA | - | in-vivo, | AD, | NA |
4289- | RES, | Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells |
- | in-vitro, | AD, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1371 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid